Related Experiment Video
Updated: Feb 6, 2026

Isolation of Endocardial and Coronary Endothelial Cells from the Ventricular Free Wall of the Rat Heart
Published on: April 15, 2020
Endocardial endothelial cell hypertrophy takes place during the development of hereditary cardiomyopathy
Danielle Jacques1, Ghassan Bkaily2
1Department of Anatomy and Cell Biology, Faculty of Medicine, Université de Sherbrooke, 3001 12th Avenue North, Sherbrooke, QC, J1H 5N4, Canada. Danielle.Jacques@USherbrooke.ca.
Insights
Endocardial endothelial cells enlarge before cardiac hypertrophy develops in hereditary cardiomyopathy. This finding reveals these cells as a potential new target for treating heart failure.
Area of Science:
- Cardiovascular Biology
- Cell Biology
- Pathology
Background:
- Endocardial endothelial cells form a barrier between blood and cardiomyocytes.
- Their role in cardiac pathologies like hypertrophy was previously unknown.
- Recent work highlighted their importance in excitation-secretion coupling.
Purpose of the Study:
- To investigate the contribution of endocardial endothelial cells to cardiac hypertrophy.
- To determine if endocardial endothelial cells undergo hypertrophy in a model of hereditary cardiomyopathy.
Main Methods:
- Utilized the UM-X7.1 hereditary cardiomyopathic hamster model.
- Isolated endocardial endothelial cells from cardiomyopathic and normal hamsters.
- Measured cell volume changes during different disease stages.
Main Results:
- Endocardial endothelial cells showed increased cell volume during necrosis, preceding cardiac hypertrophy.
- This enlarged cell volume persisted as cardiac hypertrophy developed.
- Endocardial endothelial hypertrophy was observed before cardiomyocyte hypertrophy.
Conclusions:
- Endocardial endothelial hypertrophy precedes cardiac hypertrophy in this model.
- Released factors from hypertrophied endocardial endothelial cells may drive cardiac hypertrophy.
- Endocardial endothelial cells represent a novel therapeutic target for hypertrophy and heart failure.
Abstract:
Endocardial endothelial cells constitute a barrier between the circulating blood and ventricular cardiomyocytes. Although recently our group demonstrated the importance of this type of endothelial cells in excitation-secretion coupling, there is no information on whether this type of cells contributes to cardiac pathologies such as cardiac hypertrophy. Using the well-known model of human hypertrophy and heart failure, the UM-X7.1 hereditary cardiomyopathic hamster, our results showed that during the phase of necrosis and in the absence of cardiac hypertrophy, isolated endocardial endothelial cells underwent a significant increase in cell volume compared to cells isolated from age-matched normal hamsters. This increase of the volume of endocardial endothelial cells persisted during the development of cardiac hypertrophy in the hereditary cardiomyopathic hamster. These results demonstrate for the first time, that endocardial endothelial hypertrophy precedes the development of hypertrophy in hereditary cardiomyopathy and may, via its released factors, contribute to the development of cardiac hypertrophy. These results demonstrate the importance of endocardial endothelial cells in cardiac diseases such as hypertrophy. This type of cells constitutes a new target for understanding hypertrophy and heart failure.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy VI: Nursing Management

